Angiopoietin-1 Is an Antipermeability and Anti-Inflammatory Agent In Vitro and Targets Cell Junctions
暂无分享,去创建一个
J. Gamble | M. Vadas | G. Yancopoulos | J. Drew | J. Rudge | Libby Trezise | A. Underwood | M. Parsons | Lisa Kasminkas | J R Gamble | M A Vadas | L Trezise | J Drew | A Underwood | M Parsons | L Kasminkas | J Rudge | G Yancopoulos | Anne Underwood
[1] J. Gamble,et al. Activation of Sphingosine Kinase by Tumor Necrosis Factor-α Inhibits Apoptosis in Human Endothelial Cells* , 1999, The Journal of Biological Chemistry.
[2] J. Kim,et al. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. , 2000, Circulation research.
[3] D. Cheresh,et al. Integrins, angiogenesis and vascular cell survival. , 1996, Chemistry & biology.
[4] E. Dejana,et al. Perspectives Series: Cell Adhesion in Vascular Biology Endothelial Adherens Junctions: Implications in the Control of Vascular Permeability and Angiogenesis , 1996 .
[5] J. Gamble,et al. High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway , 1999, The Journal of Biological Chemistry.
[6] J. Bischoff,et al. Noninflammatory expression of E-selectin is regulated by cell growth. , 1999, Blood.
[7] M. Corada,et al. Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). , 1996, The Journal of clinical investigation.
[8] Thomas N. Sato,et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.
[9] N. Sheibani,et al. Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype. , 1998, Molecular biology of the cell.
[10] S. Thom,et al. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. , 1993, Science.
[11] J. Alexander,et al. Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins* , 1998, The Journal of Biological Chemistry.
[12] F. Luscinskas,et al. Endothelial-dependent Mechanisms Regulate Leukocyte Transmigration: A Process Involving the Proteasome and Disruption of the Vascular Endothelial–Cadherin Complex at Endothelial Cell-to-Cell Junctions , 1997, The Journal of experimental medicine.
[13] P. Underwood,et al. Inhibition of endothelial cell adhesion and proliferation by extracellular matrix from vascular smooth muscle cells: role of type V collagen. , 1998, Atherosclerosis.
[14] M B Furie,et al. Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with interleukin-1 or tumor necrosis factor-alpha. , 1989, Journal of immunology.
[15] M. Salmon,et al. Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration. , 1999, Journal of cell science.
[16] F. Re,et al. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells , 1994, The Journal of cell biology.
[17] M. Corada,et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. Jain,et al. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. , 1999, Experimental cell research.
[19] J. Madri,et al. Platelet endothelial cell adhesion molecule-1 expression modulates endothelial cell migration in vitro. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[20] N. Glazer,et al. Angiopoietin-1 protects the adult vasculature against plasma leakage , 2000, Nature Medicine.
[21] Pamela F. Jones,et al. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.
[22] J. Zehnder,et al. The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes. , 1992, The Journal of biological chemistry.
[23] Pamela F. Jones,et al. Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.
[24] William B. Smith,et al. Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. , 1996, Journal of immunology.
[25] A. Koch,et al. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1 , 1995, Nature.
[26] M. Corada,et al. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. , 1998, Journal of cell science.
[27] B. Schleiffenbaum,et al. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. , 1989, The Journal of clinical investigation.
[28] D. Phillips,et al. PECAM-1 is required for transendothelial migration of leukocytes , 1993, The Journal of experimental medicine.
[29] J. Gamble,et al. Novel Cytokine-independent Induction of Endothelial Adhesion Molecules Regulated by Platelet/Endothelial Cell Adhesion Molecule (CD31) , 1997, The Journal of cell biology.
[30] G. Garcı́a-Cardeña,et al. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[31] P. Newman. Switched at birth: a new family for PECAM-1. , 1999, The Journal of clinical investigation.
[32] D E Ingber,et al. Fibronectin controls capillary endothelial cell growth by modulating cell shape. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[33] F. Luscinskas,et al. Monocytes Induce Reversible Focal Changes in Vascular Endothelial Cadherin Complex during Transendothelial Migration under Flow , 2000, The Journal of cell biology.
[34] P. J. Newman,et al. The biology of PECAM-1. , 1997, The Journal of clinical investigation.
[35] M. Lampugnani,et al. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[36] M. Lampugnani,et al. Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[37] B. Geiger,et al. Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells , 1994, The Journal of cell biology.
[38] A. Harris,et al. Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts , 1995, The Journal of cell biology.
[39] L. Rubin,et al. Occludin as a possible determinant of tight junction permeability in endothelial cells. , 1997, Journal of cell science.
[40] Thomas N. Sato,et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation , 1995, Nature.
[41] L. Silengo,et al. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion‐dependent cell survival , 1998, The EMBO journal.